Bisphosphonates are currently the medication of choice for both prevention and treatment of glucocorticoid-induced osteoporosis. Teriparatide has been shown to be better than alendronate and might ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

According to Indian Menopause Society, around 50 million women in India are affected by osteoporosis, with the risk significantly increasing post-menopause. The menopausal syndrome often manifests ...

US biotech Rani Therapeutics has shown that its oral formulation of a drug for osteoporosis that currently has to be delivered by injection worked as hoped in a first-in-human study. The ...

Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...

The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...